Go Freelance Jobs

How Pharmaceutical Entrepreneur Marc Beer Came To Establish Renovia Inc

Marc Beer holds over two decades of experience in the biotechnology industry, during which time he has worked with a variety of organizations. Throughout this time, he has seen a considerable amount of success, and has brought many of the firms that he worked with to the top of their respective niches. The most prominent reason behind this is that the entrepreneur has consistently looked for unique and creative solutions to the challenges that these companies face, as well as helping to grow their market share considerably.


Before entering the industry, Beer started developing his skills at Miami University, which he eventually graduated from in 1987 with a Bachelor of Science in Business. Following this, he began working in pharmaceutical sales and marketing, during which time he served with a variety of firms. One of the most notable of these during his early career was Genzyme, in which he soon began working his way up. Eventually, this led to the entrepreneur being named the firm’s Vice President of Global Marketing.


As a result of this, he was able to help the company’s product line to the 350 million potential customers that these products could benefit from. While with Genzyme, Marc Beer developed an interest in creating his firm. Armed with the skills and knowledge that he had obtained over the previous years, he decided to take the risk and left the company, eventually going on to found ViaCell. In the years following this, the pharmaceutical sales and marketing organization would go on to see a significant amount of success.


After being founded in 2000, the company would go on to be listed on the NASDAQ, as well as work on a large number of projects. In 2007, this led to the firm being sold to PerkinElmer for $300 million. However, it was soon after Marc Beer saw this success that tragedy struck, as his wife died suddenly as a result of a pulmonary embolism. This led to the entrepreneur taking an extended break from his career to look after his three children.


After a few short years, however, one of his daughters told him that he should focus back on his entrepreneurial pursuits. As a result of this, he soon saw himself becoming involved in a variety of organizations, the majority of which would see a significant amount of success. In was in 2016, however, that Marc Beer would receive an opportunity that would be too good to miss up. This began when he received a phone call from Dr. Ray Iglesias, a gynecologist with over three decades of experience treating pelvic floor disorders. Learn more: https://www.prnewswire.com/news-releases/lumenxt-names-marc-beer-chairman-of-the-board-300822547.html


In the months that would follow, the pair would create a company that would end up being called Renovia, which has seen a large amount of success since being founded. Throughout the following two years, the company would go through a variety of research and development phases, with Marc Beer eventually leading the company to release the Leva device, which received approval from the Food and Drug Administration (FDA) in April 2018.

Follow Marc Beer on Facebook

Marc Beer: Innovative Technology Will Drive Down the Cost of Treating Pelvic Floor Disorders

Marc Beer is the face behind Renovia Incorporated, a medical facility he co-founded to address the prevailing problem of pelvic floor disorders among women. The primary aim of Renovia is to develop technology-based diagnosis and treatment approaches. Since its inception in 2016, Renovia has undertaken considerable steps, most of which have been geared towards achieving its ultimate goal of providing a reliable treatment to women with urinary incontinence and fecal incontinence and other associated pelvic floor disorders.


However, to achieve his dream, Marc Beer has had to work day and night to raise funds that will support the new med-tech facility. He has had to convince various investors that the new method of treatment will offer a turnaround to diseases that are currently affecting more than 250 million people around the world. Besides proving that his treatment approach will work, Marc has to convince various investors that they are investing in an investment opportunity that will generate immediate returns.


Despite the huge challenges experienced in raising funds, Marc Beer has been able to raise sufficient funds that will support his new invention. He has been able to raise $32 million with an additional $10 million, which will be in the form of venture funding. Therefore, Marc has a total of $42 million, which will be used to push his investment forward. His new invention seems to have attracted some of the most renowned companies in the industry, such as The Longwood Fund, Perceptive Advisors, among others, which is a clear indication that he has a positive response in the market.


Besides having the necessary funds to work and start the operations of the company, Marc Beer has received good news from the Food and Drug Administration (FDA). The Federal Government body has now approved his first medical product, Leva, which forms the basis for the treatment of pelvic floor disorders. Given that the new product has already been approved, Renovia will now go ahead and produce the product in masses because funds are available.


Marc is hoping to use the new technology at Renovia to improve the services offered to women diagnosed with pelvic floor disorders. The med-tech facility is creating a digital platform that will be used by women with pelvic floor disorders to understand their unique conditions, learn about the different treatment options in the industry, and lower the health costs by understanding pelvic floor disorders and associated conditions. Learn more: https://www.prnewswire.com/news-releases/lumenxt-names-marc-beer-chairman-of-the-board-300822547.html


About Marc Beer


Every person who has worked in the pharmaceutical and biomedical industry knows Marc Beer and his input in the medical sector. His knowledge of biomedical services and advanced medical equipment put him into the global scales. He is also an excellent person in marketing services where he spent a considerable period of his career marketing pharmaceutical and biomedical products.

Follow Marc Beer on Facebook

Marc Beer

Marc Beer Does Everything He Can for Women Suffering from Pelvic Floor Disorders

Marc Beer has always been a generous man. When he worked for Genzyme after college, it was his job to promote the company’s product line. Genzyme was one of the few companies trying to treat the more than 7,000 rare diseases affecting more than 350 million people around the world.

His work at Genzyme inspired him to step up his game and do more by exploring every entrepreneurial option. Eventually, he launched ViaCell, a company that produced solutions developed from collected umbilical cord blood stem cells. In 2007, he sold that company for $300 million and planned to use that money to start up another business.

Tragically, his wife passed away suddenly after the sale. Beer was heartbroken and found solace only in raising his three children. He dedicated all of his time and energy into being a single father, but his daughter wanted more for her dad. Using the advice he gave his children every day, she encouraged him to launch another business and truly live with purpose. Learn more: https://renoviainc.com/leadership/

Around the same time, Dr. Ray Iglesias was looking for a way to help his patients avoid surgery. Dr. Iglesias is a gynecologist who inadvertently specialized in pelvic floor surgeries. The good doctor always believed there was another way to help these women, but he couldn’t figure it out by himself; he needed help, and Marc Beer was just the man to help him.

Along with Yolanda Lorie, the trio founded Renovia. Today, Beer is not only a co-founder but he’s the CEO and Chairman. The Boston-based biotech company is trying to develop therapeutic and diagnostic devices for women with pelvic floor disorders. To Beer, the company will only be successful if they can develop first-line diagnosis and treatment. Despite his immense financial success, it’s never been about money for Beer.

The number of women suffering from pelvic floor disorders is too great for Beer to ignore. According to one study, nearly one-fourth of women living in the United States are affected by these disorders. Pelvic floor disorders can cause pelvic organ prolapsed, urinary incontinence, and fecal incontinence; it’s a serious issue.

Last year, Renovia had its first big break when its first product, Leva, was approved by the FDA. Though Leva is considered a milestone successfully past, Beer won’t be satisfied until he obtains the results he’s looking for: innovative and proprietary sensor technologies and a digital health platform.

Follow Marc Beer on Facebook

Marc Beer Discusses The Future Of His Career

He has done pretty well for himself over the course of his three-decade career but that doesn’t mean Marc Beer takes any of it for granted. In fact, he is grateful for all of the things he has achieved over the years but he is always looking to the future. So what does the future look like for the 48 year old entrepreneur, philanthropist, and businessman? Well, he has said he hopes to help as many people as he can throughout his career and that his business is always about giving back to the community first and foremost. He currently serves as the co-founder, chairman, and CEO of a new business known as Renovia. Despite only being around for a few years, it has already become a huge success as they recently became a recipient of a grant worth upwards of $42 million. The Boston-based company is committed to developing medical tools for patients with a wide variety of different conditions and making them available to the people who need them by mass-producing the equipment. It is currently projected that 32 million will be used to fund their research and development while the rest will be used in their financial department to invest in whatever they see fit. One of the conditions they are currently attempting to treat affects an estimated 25% of the population, mostly females. It is known as pelvic floor disorder and it can prove to be quite serious if left untreated which is why they’re working on a new treatment. Learn more: https://blogwebpedia.com/marc-beer-entrepreneurial-spirit-biotech.html In a recent statement, he provided some words of wisdom to the next generation of aspiring businesspeople and entrepreneurs. During this time, he advised them to always focus on the needs of the patients first, enjoy the process as much you can and, above all, be willing to make sacrifices in order to ensure the company succeeds in the long run. Of course, this was not the first company he owned. Back in May of 2000, he decided to strike out on his own and become the founder and CEO of a business that later came to be known as Viacell. Located in the Cambridge area, the company was dedicated to trying to find cures for different kinds of diseases. They do this by examining stem cells typically found in the umbilical cords of new mothers. They extract them from the cord so they can analyze the cells and search for any biomarkers that may indicate a potential cure or vaccine. The company did prove to be a success, employing up to 500 people at one point and even become worth over $300 million but he soon sold it for a massive profit. Connect with Marc Beer on Facebook

Marc Beer Expects Renovia To Help Many Women Who Suffer From Pelvic Floor Disorders

Marc Beer is a businessman who has been able to accomplish more than most people during his lifetime. He has served with various companies for more than two and one half decades and has been able to help them expand. Beer studied at Miami University and received his Bachelor of Science in business there. After finishing up college, he moved on to work with Genzyme as a pharmaceutical sales and marketing specialist. He eventually worked his way up through the ranks of the company until he became its vice president of global marketing. During his time with Genzyme, he was able to help the company reach millions of under-served people who had a great need for the medical products it was offering. 


Marc Beer began to feel like he wanted to do more for people, and this feeling led him to leaving Genzyme and starting up his own company. In 2000, he launched ViaCell, and it didn’t take him long to grow the biotech company into something special. ViaCell went public in the mid 2000s and had 300 people working for it when it did so. Beer later sold the company to PerkinElmer for millions of dollars. Not long after this, his wife passed away, and this made him change directions for some time. Instead of focusing all of his energy and attention on work, he focused on taking care of his three children. Learn more: https://renoviainc.com/leadership/


After dealing with the loss of his wife for a time, Marc Beer eventually made his way back into the business world. His daughter had offered him the same words of wisdom he often offered her, and these were to live his life on purpose. This motivated Beer, and he got back in the horse by helping to create Renovia. He serves as the company’s chairman and chief executive officer, and he was inspired to help build Renovia after speaking with Dr. Iglesias. The doctor had been taking part in pelvic floor surgeries on women for more than three and one half decades, and he had an idea that would change the industry. 


Since the founding of Renovia, Marc Beer has been working hard to help women who suffer from a spread of pelvic floor disorders. In 2018, the company launched Leva, which was its first product. The company just recently finished up a round of Series B funding, and Beer commented that Renovia was happy to have the support of all of the different investors who believe in its vision. Beer has continued to give back to his community and and now serves with the Notre Dame Research and Commercialization Advisory Committee as a member. He expects to continue to work hard to reach more women who can use all of the help they can get.

Follow Marc Beer on Facebook

Tips towards appraisal of women in the workplace by Smita Shah

In this article, Smita Shah talks about significant challenges facing women in their workplaces. Due to fewer women in the top leadership in the world, women tend to lack role models, and they end up in casual careers due to lack of confidence. Shah believes that for a woman to be successful, she has to develop the right self-image by gaining experience from other successful women. She notes that in many workplaces, the presence of women has been assumed due to lack of confidence to speak for themselves. Women are unlike men in many aspects, and they face unique problems. Its time women wake from their nightmare and take high positions in industries.
It’s not a fantasy to become a successful woman: To show that women are not the less fortunate in the community, Smita Shah brought out the
ideology that women own over 100 million businesses around the world. However, this number is small compared to companies owned by men, but this does not mean that women should give up on pursuing their dreams. Shah believes that all that is needed is the commitment, decision
making, and the ability to rise in power in an organization. Smita Shah provides free tips on how a woman can succeed in her career.

Tips from Shah:

First and foremost, women should believe in themselves. Smita Shah believes that past events, whether good or bad, should act as an experience in the current endeavors. Women should treat their small achievements with respect, the same as they manage their employee’s. Instead of
leaning on the positive traits taught in society, women should be diverse and try male characteristics when it comes to business. Shah recommends that sometimes they need to get dirty to oversee a successful business as a trait of dominance.
In the business world, Smita Shah advice women to present themselves in the best way possible. First impressions are important as they define the perceptions of people from the start and states how the future is going to be. According to Shah, a woman should be decent in the traditional
mode of dressing as currently, men get confused by typical dressing, and they fail to listen to you. She further advices women that they should concentrate on fulfilling short-term goals rather than unrealistic dreams.

Learn more: https://premiergazette.com/2019/07/smita-shahs-best-practices-empowerment-workplace/
More information about Smita Shah Smita Shah is a renowned mathematician with an education background in Engineering from major
universities. She is an expert in fields such as business and public speaking. Shah founded SPAAN Technologies, an enterprise that deals with the provision of alternative technical solutions to problems in significant programs. She is an advocate of empowerment of women through sectors
such as innovation, growth of businesses, and dedication to one’s career.

Connect with Smita on LinkedIn

Marc Beer is expected to bring Leadership and Entrepreneurship Skills at LumeN XT Incorporated

Conducting surgeries in minimally invasive surgeries has been a target for many medical experts around the world. The traditional methods of performing surgical operations have caused unending pain to a considerable number of people around the world. A considerable number of people number of people are still portraying serious life deformities that were caused by surgical approaches that have for a longer period deemed not to be safe. Marc Beer is joining LumeN XT is the chairperson of the board with the sole purpose of ensuring that the organization has a clear strategic approach towards surgical innovations.


LumeN XT. Inc is an organization that has been coming up with innovative strategies that are geared towards ensuring that there are safe surgical operations for any person involved. The company has been innovative tools and equipment that make surgical operations to be less invasive, which is an approach that will enhance safety among many people around the world. The illumination technology is expected to change the current perception towards surgical operations. It is important to highlight that the current approach is far much better and attractive as compared to the traditional methods of handling surgical operations.


Surgeons who have used the current illumination technology have already stated that it is enhancing more visualization as compared to the traditional equipment. It is important to highlight that visualization is a major component of surgical operations. It is difficult for any surgeon to perform to have complete visualization of the area under consideration. Most surgical injuries have occurred due to the fact that visualization has been poor, which has caused surgeons to make grave mistakes. Other important aspects that can be noted from the current innovation include flexibility during operations and high precision as compared to traditional surgical equipment.


With this innovation become famous in the country and in other part of the world, Marc Beer is expected to take center stage in all the necessary operations. He has been highly involved in marketing of medical equipment and other pharmaceutical products, which is a clear indication that he will be playing a major role in the progress of the organization at this stage. Beer has an opportunity to solve surgical challenges by coming up with innovations that will help many people around the world.


Marc Beer has also excelled in entrepreneurship, especially after establishing ViaCell, which was an organization that was specifically focused on biotechnology. Beer established this organization after calling it time in marketing of pharmaceutical products. The biotechnological company had employed more than 300 employees, which is a clear indication that it was a big organization. Therefore, Marc is expected to bring his entrepreneurship and leadership skills at the management of this company. LumeN XT needs an experienced hand to move into the next stage of its development. Learn more: https://renoviainc.com/leadership/

“Marc Beer Joins LumeNXT’s Executive Board “

LumeNXT, Inc recently announced the appointment of Marc Beer as the firm’s Board Chairman. LumeNXT, Inc., is a private for-profit organization that deals with the creation of proprietary surgical illumination products that are used in minimally invasive surgeries. Marc Beer is bringing along with him over two decades worth of experience in pharmaceuticals, biotechnology and device development and commercialization among others.

Marc Beer in a statement regarding the appointment said that he is proud and honored to join the LumeNXT family. LumeNXT comprises of a team of dedicated and accomplished staff who have worked tirelessly to develop innovative surgical solutions through the development of proprietary technology that has enhanced minimally invasive surgery which is considered to be the safest and most precise mode of operation. Beer added that he believes that LumeNXT is destined for greatness as more surgeries are going to be performed using the firm’s technology.

Targeted illumination technology that the firm boasts of has helped enhanced visualization, precision and also flexibility during surgeries as compared to the traditional surgical methods. The LumeNXT platform utilizes the heat reduction mechanism that helps improve surgical accuracy and increases safety through enhanced visualization among other things.

In another statement concerning the appointment, LumeNXT Co-Founder Mr. Paul Rhyne said that the firm is pleased to have Marc Beer as its Board Chairman. Beer is a renowned serial entrepreneur who has successfully helped established multiple startup companies. His vast entrepreneurial experience will go a long way in assisting LumeNXT to reach greater horizons in the healthcare industry said, Rhyne.

Marc Beer current undertakings including serving as the CEO and Chairman of Renovia, Inc, a company he co-founded in 2016 to help in the treatment and diagnosis of pelvic floor disorders that is affecting the lives of millions of women worldwide. Beer before founding Renovia served in various multinational healthcare companies in senior executive roles. Among the companies that Beer has served include Minerva Neurosciences, Inc., where he served as the firms founding Chairman. Minerva Neurosciences is a biopharmaceutical firm that deals with the creation of a range of products that are aimed at treating central nervous system diseases as well as diseases such as schizophrenia, insomnia, and depressive disorders among others. Other firms that Beer has served in senior capacities include Good Start Genetics, Inc., where he served as a board chairman, ViaCell where he served as the founder and CEO, Erytech Pharma where he served at the Board of Directors and Genzyme among others. Marc Beer has an excellent academic background and holds a Bachelors of Science degree from the prestigious Miami University. Learn more: https://www.benzinga.com/pressreleases/18/08/r12237847/osf-ventures-invests-in-company-developing-solutions-for-pelvic-floor-


Clay Siegall`s Success as the Co-founder and CEO of Seattle Genetics

Dr. Clay Siegall is the co-founder of Seattle Genetics. He established the company in 1998 and became CEO, President and Chairman of the Board of Directors. During his reign, Siegall enabled Seattle Genetics to build a diverse pharmaceutical line of antibody drugs for cancer therapies such as ADCETRICS. Clay Siegall is dedicated to his work. He has a passion of combating cancer challenges. He believes he can achieve his objective through his organization.

Seattle Genetics is a company that is making great strides in the medical industry. At its headquarters is a green triangular sculpture that is made of Lego bricks. The structure shows a simple model of a human antibody. Settle Genetics has specialized in the study of human antibodies for years. Since it was established in 1998, the company has manipulated, designed and packaged antibodies into multiple drugs. The antibody must connect to something else, such as therapy. It delivers a toxic substance into the cancerous cells and destroys such tissues.

Seattle Genetics has a recorded a tremendous growth over the past 5 years. Its stock has tripled since 2013, from $20 to $60 per share. Valuations show high chances of future success. Seattle`s main focus is antibody-drug conjugate (ADC), a drug that targets antigens. The drug has been used to reduce the damage that is caused by traditional methods such as radiography and chemotherapy. Siegall believes several drugs have a high potential for success. Such include Adcetris, 33A, 22ME and LIV1.

Clay Siegall is an optimistic person who believes he will succeed regardless of the political turmoil. He notes that drug production is not easy. He has to cope with various challenges. He was mentored by Art Levinson, one of Genentech founders. He believes he has to diversify his risk by producing multiple drugs.

About Clay Siegall

Dr. Clay Siegall is a scientist who focused his research on cancer therapies. He built the organization by believing in his scientific innovations, rigorous research and unique drug development practices. He has guided Seattle Genetics to acquire its leadership position in manufacturing antibody-drug conjugates (ADC) that are used in cancer therapies.

Clay has helped the organization to acquire multiple contracts for the supply of its ADC medicine. He also helped to secure several licenses for its technology. Some of the main partners include Genentech, AbbVie, Pfizer, GlaxoSmithKline. These organizations have enabled Seattle Genetics to secure over $300 million. Dr. Siegall also led several capital-raising functions that generated over $1.2 billion, through private and public financing.